153 related articles for article (PubMed ID: 1732964)
1. Quantitative chemical shift imaging of vertebral bone marrow in patients with Gaucher disease.
Johnson LA; Hoppel BE; Gerard EL; Miller SP; Doppelt SH; Zirzow GC; Rosenthal DI; Dambrosia JM; Hill SC; Brady RO
Radiology; 1992 Feb; 182(2):451-5. PubMed ID: 1732964
[TBL] [Abstract][Full Text] [Related]
2. Quantification of bone involvement in Gaucher disease: MR imaging bone marrow burden score as an alternative to Dixon quantitative chemical shift MR imaging--initial experience.
Maas M; van Kuijk C; Stoker J; Hollak CE; Akkerman EM; Aerts JF; den Heeten GJ
Radiology; 2003 Nov; 229(2):554-61. PubMed ID: 14526090
[TBL] [Abstract][Full Text] [Related]
3. Dixon quantitative chemical shift imaging is a sensitive tool for the evaluation of bone marrow responses to individualized doses of enzyme supplementation therapy in type 1 Gaucher disease.
Hollak C; Maas M; Akkerman E; den Heeten A; Aerts H
Blood Cells Mol Dis; 2001; 27(6):1005-12. PubMed ID: 11831867
[TBL] [Abstract][Full Text] [Related]
4. Analysis of the lipids of normal and Gaucher bone marrow.
Miller SP; Zirzow GC; Doppelt SH; Brady RO; Barton NW
J Lab Clin Med; 1996 Apr; 127(4):353-8. PubMed ID: 8656038
[TBL] [Abstract][Full Text] [Related]
5. Quantification of skeletal involvement in adults with type I Gaucher's disease: fat fraction measured by Dixon quantitative chemical shift imaging as a valid parameter.
Maas M; Hollak CE; Akkerman EM; Aerts JM; Stoker J; Den Heeten GJ
AJR Am J Roentgenol; 2002 Oct; 179(4):961-5. PubMed ID: 12239046
[TBL] [Abstract][Full Text] [Related]
6. Water fraction of lumbar vertebral bone marrow estimated from chemical shift misregistration on MR imaging: normal variations with age and sex.
Ishijima H; Ishizaka H; Horikoshi H; Sakurai M
AJR Am J Roentgenol; 1996 Aug; 167(2):355-8. PubMed ID: 8686603
[TBL] [Abstract][Full Text] [Related]
7. Compositional changes in vertebral bone marrow during treatment for acute leukemia: assessment with quantitative chemical shift imaging.
Gerard EL; Ferry JA; Amrein PC; Harmon DC; McKinstry RC; Hoppel BE; Rosen BR
Radiology; 1992 Apr; 183(1):39-46. PubMed ID: 1549692
[TBL] [Abstract][Full Text] [Related]
8. Bone marrow fat quantification of osteoporotic vertebral compression fractures: comparison of multi-voxel proton MR spectroscopy and chemical-shift gradient-echo MR imaging.
Régis-Arnaud A; Guiu B; Walker PM; Krausé D; Ricolfi F; Ben Salem D
Acta Radiol; 2011 Nov; 52(9):1032-6. PubMed ID: 21948596
[TBL] [Abstract][Full Text] [Related]
9. Gaucher disease: assessment with MR imaging.
Lanir A; Hadar H; Cohen I; Tal Y; Benmair J; Schreiber R; Clouse ME
Radiology; 1986 Oct; 161(1):239-44. PubMed ID: 3763873
[TBL] [Abstract][Full Text] [Related]
10. Gaucher disease status and treatment assessment: pilot study using magnetic resonance spectroscopy bone marrow fat fractions in pediatric patients.
Degnan AJ; Ho-Fung VM; Wang DJ; Ficicioglu C; Jaramillo D
Clin Imaging; 2020 Jul; 63():1-6. PubMed ID: 32120306
[TBL] [Abstract][Full Text] [Related]
11. Guidelines for Belgian MR centers for monitoring of bone marrow involvement in patients with Gaucher disease.
Vanhoenacker FM; Maas M
JBR-BTR; 2006; 89(6):321-4. PubMed ID: 17274591
[TBL] [Abstract][Full Text] [Related]
12. The need for T₂ correction on MRS-based vertebral bone marrow fat quantification: implications for bone marrow fat fraction age dependence.
Dieckmeyer M; Ruschke S; Cordes C; Yap SP; Kooijman H; Hauner H; Rummeny EJ; Bauer JS; Baum T; Karampinos DC
NMR Biomed; 2015 Apr; 28(4):432-9. PubMed ID: 25683154
[TBL] [Abstract][Full Text] [Related]
13. Quantification of Bone Marrow Involvement in Treated Gaucher Disease With Proton MR Spectroscopy: Correlation With Bone Marrow MRI Scores and Clinical Status.
Jaramillo D; Bedoya MA; Wang DJ; Pena AH; Delgado J; Jaimes C; Ho-Fung V; Kaplan P
AJR Am J Roentgenol; 2015 Jun; 204(6):1296-302. PubMed ID: 26001241
[TBL] [Abstract][Full Text] [Related]
14. Dynamic contrast-enhanced MR imaging of the water fraction of normal bone marrow and diffuse bone marrow disease.
Katsuya T; Inoue T; Ishizaka H; Aoki J; Endo K
Radiat Med; 2000; 18(5):291-7. PubMed ID: 11128399
[TBL] [Abstract][Full Text] [Related]
15. Fat Quantification in the Vertebral Body: Comparison of Modified Dixon Technique with Single-Voxel Magnetic Resonance Spectroscopy.
Lee SH; Yoo HJ; Yu SM; Hong SH; Choi JY; Chae HD
Korean J Radiol; 2019 Jan; 20(1):126-133. PubMed ID: 30627028
[TBL] [Abstract][Full Text] [Related]
16. Quantitative imaging of Gaucher disease.
Rosenthal DI; Barton NW; McKusick KA; Rosen BR; Hill SC; Castronovo FP; Brady RO; Doppelt SH; Mankin HJ
Radiology; 1992 Dec; 185(3):841-5. PubMed ID: 1438773
[TBL] [Abstract][Full Text] [Related]
17. [Enzyme replacement therapy in Gaucher disease: monitoring visceral and bone changes with MRI].
Tóth J; Szücs FZ; Benkö K; Maródi L
Orv Hetil; 2003 Apr; 144(16):749-55. PubMed ID: 12778625
[TBL] [Abstract][Full Text] [Related]
18. MRI measurement of bone marrow cellularity for radiation dosimetry.
Pichardo JC; Milner RJ; Bolch WE
J Nucl Med; 2011 Sep; 52(9):1482-9. PubMed ID: 21799087
[TBL] [Abstract][Full Text] [Related]
19. Spontaneous regression of disease manifestations can occur in type 1 Gaucher disease; results of a retrospective cohort study.
Boomsma JM; van Dussen L; Wiersma MG; Groener JE; Aerts JM; Maas M; Hollak CE
Blood Cells Mol Dis; 2010 Mar; 44(3):181-7. PubMed ID: 20074983
[TBL] [Abstract][Full Text] [Related]
20. T2 relaxation time of bone marrow water and lipid: correlation with serum ferritin in normal individuals.
Ishijima H; Ishizaka H; Aoki J; Inoue T; Endo K
J Comput Assist Tomogr; 1997; 21(3):506-8. PubMed ID: 9135666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
